BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 3724776)

  • 1. Induction of rat hepatic mixed function oxidases by aromatic amines and its relationship to their bioactivation to mutagens.
    Steele CM; Ioannides C
    Mutat Res; 1986 Aug; 162(1):41-6. PubMed ID: 3724776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of aromatic amines to mutagens by various animal species including man.
    Phillipson CE; Ioannides C
    Mutat Res; 1983 Dec; 124(3-4):325-36. PubMed ID: 6361543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic microsomal mixed-function oxidase activity in ethanol-treated hamsters and its consequences on the bioactivation of aromatic amines to mutagens.
    Ioannides C; Steele CM
    Chem Biol Interact; 1986 Sep; 59(2):129-39. PubMed ID: 3021347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of the hepatic mixed-function oxidases by Aroclor 1254 in the hamster: comparison of Aroclor-induced rat and hamster preparations in the activation of pre-carcinogens in the Ames test.
    Hyde R; Smith JN; Ioannides C
    Mutagenesis; 1987 Nov; 2(6):477-82. PubMed ID: 3127658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of some aromatic amines to mutagenic products by human red blood cell cytosol.
    Duverger-van Bogaert M; Crutzen-Fayt MC; Stecca C
    Mutat Res; 1991 Aug; 263(4):249-55. PubMed ID: 1861690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of chronic alcohol administration to rats on the activation of aromatic amines to mutagens in the Ames test.
    Steele CM; Ioannides C
    Carcinogenesis; 1986 May; 7(5):825-9. PubMed ID: 3009048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Arylamine activation following chronic ethanol ingestion by rats: studies on the liver S9, microsomal and cytosolic fractions and comparison with Aroclor 1254 pretreatment.
    Traynor CA; Shane BS; Hajos AK; Winston GW
    Mutat Res; 1991 Mar; 247(1):153-66. PubMed ID: 2002800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative mutagenicity of plant-activated aromatic amines using Salmonella strains with different acetyltransferase activities.
    Wagner ED; Smith SR; Xin H; Plewa MJ
    Environ Mol Mutagen; 1994; 23(1):64-9. PubMed ID: 8125084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of the mutagenicity of aromatic amines by the plant flavonoid (+)-catechin.
    Steele CM; Lalies M; Ioannides C
    Cancer Res; 1985 Aug; 45(8):3573-7. PubMed ID: 4016737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver, kidney and small-intestine microsomal-mediated mutagenicity of carcinogenic aromatic amines.
    Fouarge M; Mercier M; Poncelet F
    Mutat Res; 1984 Jan; 125(1):23-31. PubMed ID: 6361544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Organ, species, and compound specificity in the metabolic activation of primary aromatic amines.
    Poupko JM; Radomski T; Santella RM; Radomski JL
    J Natl Cancer Inst; 1983 Jun; 70(6):1077-80. PubMed ID: 6574277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of highly purified cytochrome P-450 isozymes in the activation of 4-aminobiphenyl to mutagenic products in the Ames test.
    Masson HA; Ioannides C; Gorrod JW; Gibson GG
    Carcinogenesis; 1983 Dec; 4(12):1583-6. PubMed ID: 6418403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-glucuronide formation of carcinogenic aromatic amines in rat and human liver microsomes.
    Lilienblum W; Bock KW
    Biochem Pharmacol; 1984 Jul; 33(13):2041-6. PubMed ID: 6430297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The homogeneity of rat liver microsomal cytochrome P-448 activity and its role in the activation of benzo[a]pyrene to mutagens.
    Phillipson CE; Ioannides C; Barrett DC; Parke DV
    Int J Biochem; 1985; 17(1):37-42. PubMed ID: 3996731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The substrate specificity of the rat hepatic cytosolic arylamine oxidase catalyzing the bioactivation of aromatic amines.
    Marczylo T; Ioannides C
    Cancer Lett; 1998 May; 127(1-2):141-6. PubMed ID: 9619870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A rationale for the non-mutagenicity of 2- and 3-aminobiphenyls.
    Ioannides C; Lewis DF; Trinick J; Neville S; Sertkaya NN; Kajbaf M; Gorrod JW
    Carcinogenesis; 1989 Aug; 10(8):1403-7. PubMed ID: 2665965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for the presence of a microsomal NADH-dependent enzyme system that can bioactivate aromatic amines in the liver of rats and mice.
    Marczylo T; Ioannides C
    Toxicology; 1999 Jun; 134(2-3):127-41. PubMed ID: 10403632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of the rat hepatic microsomal mixed-function oxidases by cimetidine.
    Ioannides C; Rodrigues AD; Ayrton AD; Barnett CR; Chown J; Parke DV
    Toxicol Lett; 1989 Oct; 49(1):61-8. PubMed ID: 2815115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-glucuronidation of carcinogenic aromatic amines catalyzed by rat hepatic microsomal preparations and purified rat liver uridine 5'-diphosphate-glucuronosyltransferases.
    Green MD; Tephly TR
    Cancer Res; 1987 Apr; 47(8):2028-31. PubMed ID: 3103910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytosolic activation of 2-aminoanthracene: implications in its use as diagnostic mutagen in the Ames test.
    Ayrton AD; Neville S; Ioannides C
    Mutat Res; 1992 Jan; 265(1):1-8. PubMed ID: 1370238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.